SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-000591
Filing Date
2017-01-12
Accepted
2017-01-12 16:50:56
Documents
3
Period of Report
2017-01-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K insy20170112_8k.htm 8-K 29534
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 14477
3 ex99-1img004.gif GRAPHIC 3998
  Complete submission text file 0001437749-17-000591.txt   50874
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 17525547
SIC: 2834 Pharmaceutical Preparations